UPDATE 2-Amneal Pharma cuts core profit forecast on allergy shot supply issues
July 10, 2019 at 08:32 AM EDT
Amneal Pharmaceuticals Inc on Wednesday cut its 2019 core earnings forecast, citing the uncertain supply of its epinephrine auto-injectors amid a global shortage of the emergency allergy shots, including Mylan NV's EpiPen.